Chirosyn Canada Inc. launches foundation in celebration of ‘15 years of excellence in medicine in Guyana’

See below the full statement issued:

Chirosyn Canada Inc., a Canadian based, Guyanese owned pharmaceutical company, successfully launched the Dr. Cheekoori’s Medicine Foundation at their Cardiology and Endocrinology symposium held on Sunday March 16^th at the Atlantic Ballroom of the Pegasus Hotel. The Minister of Health, Dr. Frank Anthony gave the opening remarks and assisted with the ribbon cutting ceremony alongside the founding partners and owner of the company, Dr. Sreedhar Cheekoori and Tarlika Persaud. The company started distributing pharmaceutical products in 2010, before branching into pharmaceutical manufacturing. Company owners, Tarlika Persaud, a genomics specialist with a master’s degree in Chemistry, developed a novel method for detecting metabolic disorders in newborns at McMaster Hospital in Canada before jointly venturing into this field with her husband, Dr. Sreedhar Cheekoori, who owns several medicinal patents and has a doctorate in organic Chemistry from McMaster University.

This joint symposium between Chirosyn, The Medical Council and The Pharmacy Councils of Guyana hosted over 300 doctors and pharmacists across Guyana. Dr. Vivian Rambihar, who was inducted to the Walk of Fame in Canada for his outstanding contributions to the field of Cardiology, spoke on several new Cardiology theories on unpredictability within the field. Dr. Sherryn Rambihar, a Cardiologists at UHN in Canada, Dr. Nadira Rambihar, a Physiatrist at West Park Healthcare in Toronto, Dr. Gaitree Satram, Pediatrician from UWI and Dr. Karishma Jeeboo, Chairperson of the Guyana Pharmacy Council all gave academic presentations which were well received.

The Dr. Cheekoori’s Medicine foundation will assist Guyanese who lack access and experience financial need as well as expand access to a wider range of unavailable medicines in emergency circumstances. The Foundation hopes to work alongside the healthcare systems currently in Guyana.

The company plans to expand its operations in Guyana an to work alongside the Ministry of Health and local agencies to integrate the plans of the Guyana Government’s medicine initiatives.